Annual Operating Profit
$224.25 M
+$35.33 M+18.70%
31 December 2023
Summary:
Amneal Pharmaceuticals annual operaing income is currently $224.25 million, with the most recent change of +$35.33 million (+18.70%) on 31 December 2023. During the last 3 years, it has risen by +$113.17 million (+101.88%). AMRX annual operating profit is now -19.37% below its all-time high of $278.11 million, reached on 31 December 2018.AMRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$76.47 M
-$6.47 M-7.80%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly operating income is currently $76.47 million, with the most recent change of -$6.47 million (-7.80%) on 30 September 2024. Over the past year, it has dropped by -$39.00 thousand (-0.05%). AMRX quarterly operating profit is now -8.12% below its all-time high of $83.23 million, reached on 31 March 2024.AMRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$278.82 M
-$39.00 K-0.01%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM operating income is currently $278.82 million, with the most recent change of -$39.00 thousand (-0.01%) on 30 September 2024. Over the past year, it has increased by +$19.32 million (+7.44%). AMRX TTM operating profit is now -5.38% below its all-time high of $294.69 million, reached on 30 September 2018.AMRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.7% | -0.1% | +7.4% |
| 3 y3 years | +101.9% | +35.2% | +37.4% |
| 5 y5 years | -19.4% | +252.7% | +561.8% |
AMRX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +101.9% | -8.1% | +373.2% | -0.0% | +108.6% |
| 5 y | 5 years | -19.4% | +261.5% | -8.1% | +252.7% | -0.0% | +300.8% |
| alltime | all time | -19.4% | +261.5% | -8.1% | +228.8% | -5.4% | +300.8% |
Amneal Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $76.47 M(-7.8%) | $278.82 M(-0.0%) |
| June 2024 | - | $82.94 M(-0.3%) | $278.86 M(+2.8%) |
| Mar 2024 | - | $83.23 M(+130.1%) | $271.33 M(+21.0%) |
| Dec 2023 | $224.25 M(+18.7%) | $36.17 M(-52.7%) | $224.25 M(-13.6%) |
| Sept 2023 | - | $76.51 M(+1.5%) | $259.51 M(+14.4%) |
| June 2023 | - | $75.41 M(+108.6%) | $226.83 M(+11.9%) |
| Mar 2023 | - | $36.15 M(-49.4%) | $202.73 M(+7.3%) |
| Dec 2022 | $188.92 M(-2.6%) | $71.43 M(+63.0%) | $188.92 M(+41.3%) |
| Sept 2022 | - | $43.83 M(-14.6%) | $133.66 M(-8.7%) |
| June 2022 | - | $51.32 M(+129.7%) | $146.38 M(-12.4%) |
| Mar 2022 | - | $22.34 M(+38.3%) | $167.18 M(-13.8%) |
| Dec 2021 | $193.91 M(+74.6%) | $16.16 M(-71.4%) | $193.91 M(-4.5%) |
| Sept 2021 | - | $56.56 M(-21.6%) | $202.97 M(+35.1%) |
| June 2021 | - | $72.11 M(+47.0%) | $150.22 M(+62.8%) |
| Mar 2021 | - | $49.07 M(+94.5%) | $92.28 M(-16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $111.08 M(-180.0%) | $25.22 M(+561.7%) | $111.08 M(+61.0%) |
| Sept 2020 | - | $3.81 M(-73.1%) | $68.98 M(+357.0%) |
| June 2020 | - | $14.17 M(-79.1%) | $15.10 M(-229.8%) |
| Mar 2020 | - | $67.87 M(-502.2%) | -$11.63 M(-91.6%) |
| Dec 2019 | -$138.89 M(-149.9%) | -$16.88 M(-66.3%) | -$138.89 M(+130.0%) |
| Sept 2019 | - | -$50.07 M(+298.7%) | -$60.38 M(-189.4%) |
| June 2019 | - | -$12.56 M(-78.8%) | $67.57 M(-54.4%) |
| Mar 2019 | - | -$59.38 M(-196.3%) | $148.04 M(-46.8%) |
| Dec 2018 | $278.11 M(+23.5%) | $61.64 M(-20.8%) | $278.11 M(-5.6%) |
| Sept 2018 | - | $77.87 M(+14.7%) | $294.69 M(+6.6%) |
| June 2018 | - | $67.91 M(-3.9%) | $276.38 M(+9.2%) |
| Mar 2018 | - | $70.69 M(-9.6%) | $253.16 M(+38.7%) |
| Dec 2017 | $225.19 M(-17.8%) | $78.22 M(+31.3%) | $182.47 M(+75.0%) |
| Sept 2017 | - | $59.56 M(+33.3%) | $104.24 M(+133.3%) |
| June 2017 | - | $44.69 M | $44.69 M |
| Dec 2016 | $273.95 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual operating profit year-on-year change?
- What is Amneal Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly operating profit year-on-year change?
- What is Amneal Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM operating profit year-on-year change?
What is Amneal Pharmaceuticals annual operaing income?
The current annual operating profit of AMRX is $224.25 M
What is the all time high annual operating profit for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual operaing income is $278.11 M
What is Amneal Pharmaceuticals annual operating profit year-on-year change?
Over the past year, AMRX annual operaing income has changed by +$35.33 M (+18.70%)
What is Amneal Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AMRX is $76.47 M
What is the all time high quarterly operating profit for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly operating income is $83.23 M
What is Amneal Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, AMRX quarterly operating income has changed by -$39.00 K (-0.05%)
What is Amneal Pharmaceuticals TTM operating income?
The current TTM operating profit of AMRX is $278.82 M
What is the all time high TTM operating profit for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM operating income is $294.69 M
What is Amneal Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, AMRX TTM operating income has changed by +$19.32 M (+7.44%)